PRELUDE CAPITAL MANAGEMENT, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 78 filers reported holding NEOS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 21.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$189,000
-22.2%
38,9080.0%0.01%
-26.7%
Q2 2018$243,000
-39.7%
38,908
-19.8%
0.02%
-48.3%
Q1 2018$403,000
-13.5%
48,532
+6.1%
0.03%
-21.6%
Q4 2017$466,000
-45.0%
45,721
-50.6%
0.04%
-51.3%
Q3 2017$847,000
+81.0%
92,567
+44.3%
0.08%
+72.7%
Q2 2017$468,000
+108.9%
64,157
+105.9%
0.04%
+109.5%
Q1 2017$224,000
+163.5%
31,157
+113.6%
0.02%
+110.0%
Q4 2016$85,00014,5870.01%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders